IS3987A - Efnablöndur sem innihalda N-(fosfónóasetýl)-L-asparsýru og aðferðir við notkun þeirra sem breiðvirkefni gegn veirum - Google Patents

Efnablöndur sem innihalda N-(fosfónóasetýl)-L-asparsýru og aðferðir við notkun þeirra sem breiðvirkefni gegn veirum

Info

Publication number
IS3987A
IS3987A IS3987A IS3987A IS3987A IS 3987 A IS3987 A IS 3987A IS 3987 A IS3987 A IS 3987A IS 3987 A IS3987 A IS 3987A IS 3987 A IS3987 A IS 3987A
Authority
IS
Iceland
Prior art keywords
phosphonoacetyl
methods
aspartic acid
antiviral agent
preparations containing
Prior art date
Application number
IS3987A
Other languages
English (en)
Icelandic (is)
Inventor
A. Blough Herbert
Original Assignee
U.S. Bioscience, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/032,234 external-priority patent/US5491135A/en
Application filed by U.S. Bioscience, Inc. filed Critical U.S. Bioscience, Inc.
Publication of IS3987A publication Critical patent/IS3987A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IS3987A 1992-03-18 1993-03-18 Efnablöndur sem innihalda N-(fosfónóasetýl)-L-asparsýru og aðferðir við notkun þeirra sem breiðvirkefni gegn veirum IS3987A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85345492A 1992-03-18 1992-03-18
US08/032,234 US5491135A (en) 1992-03-18 1993-03-17 Compositions of N-(phosphonoacetyl)-L-aspartic acid and methods of their use as broad spectrum antivirals

Publications (1)

Publication Number Publication Date
IS3987A true IS3987A (is) 1993-09-19

Family

ID=26708159

Family Applications (1)

Application Number Title Priority Date Filing Date
IS3987A IS3987A (is) 1992-03-18 1993-03-18 Efnablöndur sem innihalda N-(fosfónóasetýl)-L-asparsýru og aðferðir við notkun þeirra sem breiðvirkefni gegn veirum

Country Status (10)

Country Link
EP (1) EP0660710A1 (he)
JP (1) JPH07507770A (he)
CN (1) CN1080853A (he)
AU (1) AU3965993A (he)
BR (1) BR9306123A (he)
CA (1) CA2109435C (he)
IL (1) IL105090A (he)
IS (1) IS3987A (he)
MX (1) MX9301527A (he)
WO (1) WO1993018763A1 (he)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US20030100532A1 (en) 1997-02-14 2003-05-29 Gary S. Jacob Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
JP2001522833A (ja) 1997-11-10 2001-11-20 ジー・ディー・サール・アンド・カンパニー 多剤耐性を治療するためのアルキル化イミノ糖類の使用
US6689759B1 (en) 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
CA2319713C (en) 1998-02-12 2012-06-26 G.D. Searle & Co. Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
ES2311921T3 (es) 1999-02-12 2009-02-16 United Therapeutics Corporation N-(8,8,8-trifluorooctil)1-5,-didesoxi-1,5-imino-d-glucitol para tratar infecciones por el virus de la hepatitis.
US6515028B1 (en) 1999-02-12 2003-02-04 G.D. Searle & Co. Glucamine compounds for treating hepatitis virus infections
WO2001045727A2 (en) * 1999-12-20 2001-06-28 New Pharma Research Sweden Ab Stabilized veterinary compositions comprising more than one antiviral agent
DE10138912A1 (de) * 2001-08-08 2003-02-27 Medinnova Ges Med Innovationen Verwendung von Wirksubstanzen zur Prophylaxe und/oder Therapie von Viruserkrankungen sowie Testsystem zum Auffinden solcher Wirksubstanzen
DE10343365A1 (de) * 2003-09-17 2005-04-14 Biosphings Ag Pharmazeutische Formulierungen von Xanthogenaten und Hemmstoffen der viralen Nukleinsäurereplikation
US8236768B2 (en) 2008-10-03 2012-08-07 3B Pharmaceuticals, Inc. Topical antiviral formulations
CN111317733B (zh) * 2020-03-24 2022-07-12 中国人民解放军海军军医大学 利福霉素类抗生素在制备抗黄热病毒感染药物中的应用
WO2021189444A1 (zh) * 2020-03-24 2021-09-30 中国人民解放军海军军医大学 利福霉素类抗生素在制备抗黄热病毒感染药物中的应用
CN111419839A (zh) * 2020-03-31 2020-07-17 远见生物科技（上海）有限公司 利福霉素的新用途
JPWO2021221111A1 (he) * 2020-04-30 2021-11-04
WO2022200615A1 (en) * 2021-03-26 2022-09-29 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Pyrimidine biosynthesis inhibitor combination for use in treating viral infections

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4178306A (en) * 1978-08-10 1979-12-11 Parsons Jack L Preparation of N-(phosphonoacetyl)-L-aspartic acid

Also Published As

Publication number Publication date
IL105090A0 (en) 1994-08-26
CA2109435C (en) 1997-03-11
BR9306123A (pt) 1997-08-26
EP0660710A4 (en) 1995-03-02
CN1080853A (zh) 1994-01-19
AU3965993A (en) 1993-10-21
IL105090A (he) 1998-08-16
WO1993018763A1 (en) 1993-09-30
EP0660710A1 (en) 1995-07-05
MX9301527A (es) 1994-02-28
JPH07507770A (ja) 1995-08-31
CA2109435A1 (en) 1993-09-19

Similar Documents

Publication Publication Date Title
IS3987A (is) Efnablöndur sem innihalda N-(fosfónóasetýl)-L-asparsýru og aðferðir við notkun þeirra sem breiðvirkefni gegn veirum
GB2144326B (en) Topical preparations containing acetyl-salicylic acid
GB1548553A (en) Addition compound of dipeptide derivative and amino acid derivative
HUT41765A (en) Herbicide composition containing 5-amino-1-pyridyl-pyrazole derivatives and process for producing the active agents
ZA892922B (en) Biphenylacetic acid gel(3%)
HU906721D0 (en) Methylene-diphosphonic acid derivatives and inflammation-preventing preparations containing them as active agents
ZA931934B (en) Compostitions of N-(phosphonoacetyl)-L-aspartic acid and methods of their use as broad spectrum antivirals
NO930760L (no) Substituerte fenyleddiksyreamider
DE3279468D1 (en) Peptide synthesis and amino acid blocking agents
GB8524879D0 (en) N-substituted amino acid derivatives
JPS57118564A (en) Amino acid derivative and manufacture
PH15717A (en) N-(1-(3-benzoylpropyl)-4-piperidyl)-sulfonic acid amides and salts thereof
NO930722L (no) Imidazolylsubstituerte fenyleddiksyreamider
DE59107135D1 (de) Phoshponsäure- und Thionophosphonsäure-Derivate
IL72157A (en) 6-alpha-hydroxyethyl-2-substituted-2-penem-3-carboxylic acid derivatives and pharmaceutical compositions comprising them
DK156484A (da) Aminosyrederivater
DK438283D0 (da) Syrestabilt alpha-amylaseenzymprodukt og fremstilling deraf
DK489384A (da) 6alfa-(1-hydroxyethyl)-2-(dioxacycloalkyl)alkylthio-2-penem-3-carboxylsyre-forbindelser og farmaceutisk praeparat
DK489584A (da) 6alfa-(1-hydroxyethyl)-2-azacycloalkylthio-2-penem-3-carboxylsyre-forbindelser og farmaceutisk praeparat
IL72602A (en) 2(5-isopropyl-5-methyl-4-oxo-1-imidazolin-2-yl)benzoic acid analogs and use thereof as herbicidal agents
ZA899114B (en) Amino acid derivatives
JPS5481205A (en) Amine and amino acid derivatives
DK344384D0 (da) 2-heterocyclylalkylthio-6-(alfa-hydroxyethyl)-2-penem-3-carboxylsyre-forbindelser og farmaceutiske praeparater indeholdende disse
ZA892059B (en) Amino acid derivatives
KR900007857A (ko) 1,4,2-옥사자포스폴리딘-4-아세트산, 2-알콕시-2-옥사이드의 아민염